To clarify these effects, we examined the relationship of Hb indices including admission, nadir, discharge and change in Hb level with 3-month functional outcome in a large hospital-based stroke registry, adjusting for RBC transfusion and for medical comorbidities using the comprehensive Charlson Comorbidity Index (CCI). The gene discussed is GSTM1; the disease is stroke disorder.